rottlerin

Rottlerin is a lipid of Polyketides (PK) class. Rottlerin is associated with abnormalities such as PARAGANGLIOMAS 2, Hyperostosis, Diffuse Idiopathic Skeletal, Virus Diseases, Perisylvian syndrome and Autoimmune disease (systemic) NOS. The involved functions are known as Apoptosis, Regulation, Signal Transduction, inhibitors and Proteasome Inhibitors [MoA]. Rottlerin often locates in Clone, Membrane, Body tissue, Plasma membrane and soluble. The associated genes with Rottlerin are XIAP gene, GAPDH gene, ICAM1 gene, P4HTM gene and TNFSF10 gene. The related lipids are Promega, Fatty Acids, Sphingolipids, Lipopolysaccharides and Saponin. The related experimental models are Mouse Model, Xenograft Model and Cancer Model.

Cross Reference

Introduction

To understand associated biological information of rottlerin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with rottlerin?

rottlerin is suspected in Infection, Morphologically altered structure, Ischemia, Pulmonary Edema, Asthma, Cardiovascular Diseases and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with rottlerin

MeSH term MeSH ID Detail
MERRF Syndrome D017243 1 associated lipids
Hyperhomocysteinemia D020138 6 associated lipids
Rhabdomyosarcoma D012208 7 associated lipids
Chlamydia Infections D002690 7 associated lipids
Renal Insufficiency, Chronic D051436 9 associated lipids
Neoplasms, Experimental D009374 10 associated lipids
Astrocytoma D001254 15 associated lipids
Hypertrophy D006984 16 associated lipids
Translocation, Genetic D014178 20 associated lipids
Neoplasms, Hormone-Dependent D009376 23 associated lipids
Per page 10 20 50 | Total 39

PubChem Associated disorders and diseases

What pathways are associated with rottlerin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with rottlerin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with rottlerin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with rottlerin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with rottlerin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with rottlerin?

Cancer Model

Cancer Model are used in the study 'Rottlerin stimulates apoptosis in pancreatic cancer cells through interactions with proteins of the Bcl-2 family.' (Ohno I et al., 2010) and Cancer Model are used in the study 'Rottlerin induces Wnt co-receptor LRP6 degradation and suppresses both Wnt/β-catenin and mTORC1 signaling in prostate and breast cancer cells.' (Lu W et al., 2014).

Mouse Model

Mouse Model are used in the study 'Neuroprotective effect of protein kinase C delta inhibitor rottlerin in cell culture and animal models of Parkinson's disease.' (Zhang D et al., 2007).

Xenograft Model

Xenograft Model are used in the study 'Rottlerin stimulates apoptosis in pancreatic cancer cells through interactions with proteins of the Bcl-2 family.' (Ohno I et al., 2010).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with rottlerin

Download all related citations
Per page 10 20 50 100 | Total 547
Authors Title Published Journal PubMed Link
Bae JH et al. Susceptibility to natural killer cell-mediated lysis of colon cancer cells is enhanced by treatment with epidermal growth factor receptor inhibitors through UL16-binding protein-1 induction. 2012 Cancer Sci. pmid:21951556
Maioli E et al. Rottlerin and curcumin: a comparative analysis. 2012 Ann. N. Y. Acad. Sci. pmid:22758638
Narumi K et al. Regulation of human monocarboxylate transporter 4 in skeletal muscle cells: the role of protein kinase C (PKC). 2012 Int J Pharm pmid:22426323
Li Z et al. Role of PKC-ERK signaling in tamoxifen-induced apoptosis and tamoxifen resistance in human breast cancer cells. 2012 Oncol. Rep. pmid:22427054
Shin EJ et al. Role of oxidative stress in methamphetamine-induced dopaminergic toxicity mediated by protein kinase Cδ. 2012 Behav. Brain Res. pmid:22512859
Latorre E et al. Downregulation of HuR as a new mechanism of doxorubicin resistance in breast cancer cells. 2012 Mol. Cancer pmid:22436134
Haines RJ et al. Protein kinase Cα phosphorylates a novel argininosuccinate synthase site at serine 328 during calcium-dependent stimulation of endothelial nitric-oxide synthase in vascular endothelial cells. 2012 J. Biol. Chem. pmid:22696221
Huang CY et al. Thrombin induces epidermal growth factor receptor transactivation and CCL2 expression in human osteoblasts. 2012 Arthritis Rheum. pmid:22674286
Alapati K et al. uPAR and cathepsin B knockdown inhibits radiation-induced PKC integrated integrin signaling to the cytoskeleton of glioma-initiating cells. 2012 Int. J. Oncol. pmid:22641287
Kolasa E et al. Phorbol ester-modulation of estrogenic genomic effects triggered by the environmental contaminant benzanthracene. 2012 Toxicol In Vitro pmid:22643241
Yun N et al. Differential consequences of protein kinase C activation during early and late hepatic ischemic preconditioning. 2012 J Physiol Sci pmid:22359070
Lim JH et al. Rottlerin induces apoptosis of HT29 colon carcinoma cells through NAG-1 upregulation via an ERK and p38 MAPK-dependent and PKC δ-independent mechanism. 2012 Chem. Biol. Interact. pmid:22410117
Hsu YC et al. Ciliogenic RFX transcription factors regulate FGF1 gene promoter. 2012 J. Cell. Biochem. pmid:22415835
Jäntti MH et al. OX1 orexin/hypocretin receptor activation of phospholipase D. 2012 Br. J. Pharmacol. pmid:21718304
Schug TT Targeting transcription through inhibition of TBP. 2011 Jan-Feb Oncotarget pmid:21378415
Ko NY et al. Interleukin-32α production is regulated by MyD88-dependent and independent pathways in IL-1β-stimulated human alveolar epithelial cells. 2011 Jan-Feb Immunobiology pmid:20430472
Kim H et al. EGFR inhibitors enhanced the susceptibility to NK cell-mediated lysis of lung cancer cells. 2011 J. Immunother. pmid:21499124
Chung YW et al. Dual function of protein kinase C (PKC) in 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced manganese superoxide dismutase (MnSOD) expression: activation of CREB and FOXO3a by PKC-alpha phosphorylation and by PKC-mediated inactivation of Akt, respectively. 2011 J. Biol. Chem. pmid:21705328
Park EJ and Kwon TK Rottlerin enhances IL-1β-induced COX-2 expression through sustained p38 MAPK activation in MDA-MB-231 human breast cancer cells. 2011 Exp. Mol. Med. pmid:21971413
Chen Z et al. Protein kinase Cδ inactivation inhibits cellular proliferation and decreases survival in human neuroendocrine tumors. 2011 Endocr. Relat. Cancer pmid:21990324